Concepedia

Marthe Minderman

MM

Statistics

Publications

6

Citations

273

H-Index

6

Active since

1996

Affiliations

Amsterdam University Medical Centers(Current)

University of Amsterdam

West German Heart and Vascular Center Essen

Roswell Park Comprehensive Cancer Center

Amsterdam Neuroscience

Marthe Minderman is an author at Amsterdam University Medical Centers specializing in oncology, life sciences, and therapeutic drug resistance.

Publications per year

1996–2024

6

Publications

6

Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation

Martijn H. den Brok, Christian Büll, Melissa Wassink et al. · Nature Communications · 2016 · 143 citations · Full text

Life Sciences, Immunology, Oncology +17

DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux

Hans Minderman, U. Vanhoefer, Károly Tóth et al. · Cytometry · 1996 · 69 citations · Full text

Medicine, Biochemistry, Pharmacology +16

MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas

Marthe Minderman, Hildo C. Lantermans, Leonie J. Grüneberg et al. · Blood Cancer Journal · 2023 · 25 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance

Hans Minderman, U. Vanhoefer, Károly Tóth et al. · Cancer · 1996 · 13 citations

Medicine, Oncology, Pharmacology +14

The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain

Marthe Minderman, Hildo C. Lantermans, Carmen van der Zwaan et al. · Blood Cancer Journal · 2023 · 13 citations · Full text

Life Sciences, Immunology, Oncology +16

1–5 of 6